An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
Clinical trial NCT01557348 · COMPLETED
Trial details
- NCT number
- NCT01557348
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-06-01
- Primary completion
- 2012-03-01
- Enrollment
- 1239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.